Ratings NextCure, Inc.

Equities

NXTC

US65343E1082

Real-time Estimate Cboe BZX 12:15:40 2024-03-28 pm EDT 5-day change 1st Jan Change
2.01 USD +3.88% Intraday chart for NextCure, Inc. +19.64% +76.32%

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Biotechnology & Medical Research

1st Jan change Capi. Investor Rating ESG Refinitiv
+75.44% 53.99M -
C
+3.30% 108B
B+
+9.90% 104B
B+
+6.49% 23.66B
B
-11.88% 22.1B
B+
-3.29% 19.71B
A-
-35.36% 18.2B
A-
-13.21% 16.19B
B
+4.99% 13.72B
C+
+34.75% 12.22B
C+
Investor Rating
-
Trading Rating
ESG Refinitiv

Financials

Sales growth
-
Earnings Growth
-
EBITDA / Sales
-
Profitability
-
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
-
4 months Revenue revision
-
7 days Revenue revision
-
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes